ERKNET and TMA patients in Europe
Very little is heard from ERKNet (European Rare Kidney Disease Network) these days. Global Action used to have articles about its…
Why a vaccine is such a controversy in aHUS/cTMA
Vaccines simulate a specific infection and through a well developed process stimulate the adaptive immune system to create antibodies and killer…
aHUS Newsletter: May 2026 Edition
aHUS Global Advocate Newsletter: May 2026 Edition Where can you get aHUS news that’s independent, objective, and focused on what’s important…
This aHUS website’s 800th blog article
Reaching the 800th article on this website is a remarkable achievement. It has taken 10 years since the website was launched.…
The 2024 Global aHUS Poll Progress
When conceived it was known from previous experiences that having a global poll about aHUS was going to be a major…
cTMA but not aHUS
The name atypical hemolytic uremic syndrome is being replaced. Complement mediated thrombotic microangiopathy is becoming a popular choice. The first term…
Another chat about vaccinations and aHUS/cTMA
Hi I heard your recent vaccination conversation with someone about deciding whether to vaccinate or not when a predisposition to aHUS…
Not too little not too much complement
Complement is known to be a collection of components which act individually and collectively to protect the body from something foreign…
aHUS Research Updates – April 2026
What’s new in aHUS research? Quite a bit, if you consider that over four dozen publications have just been added to…
- 1
- 2
- 3
- 4
- …
- 89
- Go to the next page